-
Loading metrics
No Survival Benefit from Adding Cetuximab or Panitumumab to Oxaliplatin-Based Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer in KRAS Wild Type Patients: A Meta-Analysis
- Si-wei Zhou,
- Yuan-yuan Huang,
- Ying Wei,
- Zhi-min Jiang,
- Yuan-dong Zhang,
- Qiong Yang,
- De-rong Xie
x
- Published: November 30, 2012
- https://doi.org/10.1371/journal.pone.0050925